var info = new Array();

info[1] = "<h1>Sirigen</h1><h1>The Company:</h1>Sirigen has proprietary platform amplification technology that is addressing both the biotech and life sciences sectors. Having already gained some commercial traction from several early adopters, Sirigen was looking to identify someone to chair the company and help drive its growth, In order to sell into the large multinational pharmaceuticals companies it was targeting, it was essential that the new chairman was both an industry heavyweight who could open doors for the company, but also someone experienced of working with early stage companies.<br /><br /><h1>Seraphim Lead Angel:</h1>Drummond Paris joined the Sirigen board as Non-Executive Chairman and Seraphim's lead investor. Drummond had spent more than 25 years working for Novartis - one of the world's biggest life science companies and one of Sirigen's largest potential customers. He ran Novartis' UK business from 2001 to 2005 as CEO, prior to which he held the position of Global Head of Novartis' Transplantation and Immunology Unit, which has direct relevance to Sirigen's core target market of immunodiagnostics. Drummond is also the Chairman of Karus Therapeutics - another venture-backed biotech company. Drummond therefore has an excellent blend of deep sector experience, intimate knowledge of one of Sirigen's largest potential customers and previous experience of working with early-stage companies. ";
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
info[2] = "<h1>Testplant</h1><h1>The Company:</h1>Testplant has developed some unique software that automates the process for testing other software products. It already has an exceptionally strong customer base that includes 16 Fortune 500 companies. It is now seeking to fuel the next stage of its growth by targeting more large enterprises, expanding into Asia, and acquiring complementary technology offerings to cross sell into its customer base. In order to help manage the challenges such a growth strategy would pose, Testplant's Management recognised the need to supplement the board with someone who had a track record of aggressively growing a business in the sector.<br /><br /><h1>Seraphim Lead Angel:</h1>David Harrison joined the Testplant board as Non Executive Director and Seraphim's lead investor. David was previously the Managing Director (EMEA) for Mercury Interactive. Mercury was the market leader in software testing before being acquired by HP in July 2006 for $4.5billion. David oversaw Mercury's growth in EMEA from employing just 10 people to more than 300 people and a customer base that included 75% of FTSE 100 companies. David also managed two acquisitions and launched two new business streams. As such, David is the ideal candidate to help drive Testplant's own growth.";

info[3] = "<h1>Sharpcards:</h1><h1>The Company:</h1>Sharpcards is the pioneer of mobile greeting cards - a new form of content for mobile phones. Sharpcards already works with many of the world's leading mobile network operators across the UK, US, Europe, Asia and Australasia. As a business that already had operations in four continents, the Company recognised that for its next phase of growth - which would see it collaborating with handset manufacturers to integrate its pioneering enhanced messaging application directly into handsets - it needed to bring in someone with experience of managing growth of rapidly expanding international businesses operating in the mobile content industry.<br /><br /><h1>Seraphim Lead Angel:</h1>Andrew Falcon joined the Sharpcards board as Non Executive Director and Seraphim's lead angel. Andrew was previously the COO of iTouch plc. He was a key member of the team that grew iTouch from a South African start-up into one of the world's largest providers of mobile content with operations in more than 20 countries. He oversaw iTouch's £200 million listing on the London Stock Exchange in 2000 and subsequent sale to a large Japanese trade buyer in 2004, before participating in the MBO which re-acquired iTouch in 2007 and then sold it on to Buongiorno to create the world's largest mobile entertainment provider. During his time at iTouch, Andrew was also responsible for acquiring and integrating some 30 companies. Given his background, Andrew represented an outstanding fit with Sharpcards requirements.";